Canaccord Adams maintains a 'Buy' on NuVasive, Inc. (Nasdaq: NUVA) and "Best Idea" designation. Price tareget increased from $34 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE